Workflow
类ALS综合征
icon
Search documents
大医晓病 | 樊东升:早诊断、早治疗对渐冻症患者至关重要
Jing Ji Guan Cha Wang· 2025-09-05 08:45
Core Insights - Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is characterized by the gradual loss of motor neurons in the brain and spinal cord, leading to muscle atrophy and loss of motor function [2][3] - ALS is classified as a neurodegenerative disease, similar to Alzheimer's and Parkinson's, and is currently considered incurable, with treatment focused on stabilizing or delaying the progression of the disease [2][3] Drug Availability - Currently, there are "two and a half" drugs available for ALS treatment: Riluzole from Sanofi, Edaravone from Mitsubishi Pharma, and Tofersen from Biogen, which is effective for only 2% of patients [4] Patient Symptoms and Disease Progression - Early symptoms of ALS may include insomnia, anxiety, and weight loss, with later stages leading to speech difficulties, swallowing issues, and abnormal bowel and bladder function [5][9] - The disease progresses rapidly, with many patients having a life expectancy of around five years post-diagnosis [4] Quality of Life Improvement - Early diagnosis and treatment are crucial, as the average delay in diagnosis has historically been 10-11 months, but awareness is improving, allowing for earlier intervention [6] - Early diagnosis is also vital for new drug development, as clinical trials often require early-stage patients [6] Disease Mechanisms and Triggers - The exact causes of ALS remain unclear, but potential mechanisms include excessive neuronal excitation, insufficient energy metabolism, and oxidative stress [9][10] - Factors such as weight loss, high-altitude exposure, and physical or mental stress can accelerate the onset of ALS symptoms [9][10] Misconceptions and Myths - There is a condition known as "pseudo-ALS" that mimics ALS but has a clear cause and can be treated effectively, with about 5% of suspected ALS cases falling into this category [11] - The placebo effect is a significant concern in ALS treatment, as patients may perceive improvements that are not clinically substantiated [11] Technological Advancements - Brain-computer interfaces could significantly enhance the quality of life for ALS patients by enabling communication and interaction with the outside world, especially in advanced stages of the disease [12]
樊东升:早诊断、早治疗对渐冻症患者至关重要
Jing Ji Guan Cha Wang· 2025-09-05 08:35
Core Insights - Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is characterized by the gradual loss of motor neurons in the brain and spinal cord, leading to muscle atrophy and loss of motor function, making it a neurodegenerative disease that is irreversible [1][2] Group 1: Disease Characteristics - ALS is often referred to as the "most cruel rare disease" because, unlike other neurodegenerative diseases such as Alzheimer's, patients retain cognitive and emotional functions while losing physical abilities, resulting in profound psychological pain [2] - The progression of ALS is rapid, with many patients having a life expectancy of only around five years post-diagnosis, making it more aggressive compared to other neurodegenerative diseases [3] Group 2: Available Treatments - Currently, there are limited treatment options for ALS, including riluzole from Sanofi, edaravone from Mitsubishi Pharma, and tofersen injection from Biogen, which is effective for only 2% of patients [3] Group 3: Patient Symptoms and Diagnosis - Early symptoms of ALS may include non-motor symptoms such as insomnia, anxiety, and weight loss, which can precede the onset of motor symptoms [4] - Early diagnosis is crucial, as it allows for timely treatment and can significantly extend survival rates; the average delay in diagnosis has decreased from 10-11 months to as little as 3-6 months due to increased awareness [4] Group 4: Disease Mechanisms and Risk Factors - The exact causes of ALS remain unclear, but several mechanisms have been proposed, including excessive neuronal excitation, insufficient energy metabolism, and oxidative stress [5][6] - Factors such as weight loss, high-altitude exposure, and physical or mental stress can exacerbate the condition, with studies indicating that rapid weight loss correlates with faster disease progression [6][7] Group 5: Misconceptions and Myths - There exists a condition known as "pseudo-ALS" or "ALS-like syndrome," which can be misdiagnosed as ALS but has identifiable causes and can be treated effectively [8] - The placebo effect is a significant concern in ALS treatment, as patients may perceive improvements that are not clinically substantiated [8] Group 6: Future Technologies - Brain-computer interfaces hold promise for improving the quality of life for ALS patients, particularly in late stages where communication becomes severely limited, potentially allowing patients to express thoughts and maintain a connection with the outside world [9]